Occult stage IIIA-N2 patients have excellent overall survival with initial surgery
When evaluating side effects, the following frequencies are used as a basis: Very common: more than 1 in 10 people Common: less than 1 in 10, but more than 1 in 100 patients Uncommon: less than 1 in 100, but more than 1 in 1000 patients Rare: less than 1 in 1,000 but more than 1 in 10,000 patients Very rare: less than 1 in 10,000 patients treated, or unknown
Here, we found that repression of C32E8.9 leads to profound lipidome reprogramming shifting from short saturated to long, more unsaturated lipids, especially manifesting in TGs
In plain words, it may move the balance toward make more, break less, depending on the setting and the dose
If reactions persist, talk with your provider about reconstituting with more fluid to dilute the dose (e.g., 2mL vs